Emmanuel Morélon

Detection of Kidney Allograft Rejection Using Urinary Chemokines

Microvascular Inflammation of Kidney Allografts and Clinical Outcomes

Insights from the BKEVER Trial comparing everolimus versus mycophenolate mofetil for BK Polyomavirus infection in kidney transplant recipients

Antibody Mediated Rejection and T-cell Mediated Rejection Molecular Signatures Using Next-Generation Sequencing in Kidney Transplant Biopsies

An automated histological classification system for precision diagnostics of kidney allografts

Nonskeletal and skeletal effects of high doses versus low doses of vitamin D3 in renal transplant recipients: Results of the VITALE (VITamin D supplementation in renAL transplant recipients) study, a randomized clinical trial

Infection or a third dose of mRNA vaccine elicits neutralizing antibody responses against SARS-CoV-2 in kidney transplant recipients

Inverted direct allorecognition triggers early donor-specific antibody responses after transplantation

Predictive factors of a viral neutralizing humoral response after a third dose of COVID-19 mRNA vaccine

First World Consensus Conference on pancreas transplantation: Part II – recommendations

A prospective observational study for justification, safety, and efficacy of a third dose of mRNA vaccine in patients receiving maintenance hemodialysis

The ROMANOV study found impaired humoral and cellular immune responses to SARS-CoV-2 mRNA vaccine in virus-unexposed patients receiving maintenance hemodialysis

Pretransplant Comprehensive Geriatric Assessment in Older Patients with Advanced Chronic Kidney Disease

An initial report from the French SOT COVID Registry suggests high mortality due to COVID-19 in recipients of kidney transplants

IMPact of the COVID-19 epidemic on the moRTAlity of kidney transplant recipients and candidates in a French Nationwide registry sTudy (IMPORTANT)

Missing Self-Induced Activation of NK Cells Combines with Non-Complement-Fixing Donor-Specific Antibodies to Accelerate Kidney Transplant Loss in Chronic Antibody-Mediated Rejection

An extension of the RITUX‐ERAH study, multicenter randomized clinical trial comparing rituximab to placebo in acute antibody‐mediated rejection after renal transplantation

Prediction system for risk of allograft loss in patients receiving kidney transplants: international derivation and validation study

Missing self triggers NK cell-mediated chronic vascular rejection of solid organ transplants

An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients

Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation (TRIMECO): a multicentre, randomised controlled trial

Chronic rejection in vascularized composite allotransplantation

Face Transplantation: Partial Graft Loss of the First Case 10 Years Later

Endothelial chimerism and vascular sequestration protect pancreatic islet grafts from antibody-mediated rejection

Increasing incidence of melanoma after solid organ transplantation: a retrospective epidemiological study

Computer-assisted topological analysis of renal allograft inflammation adds to risk evaluation at diagnosis of humoral rejection

Pregnancy outcomes in simultaneous pancreas and kidney transplant recipients: a national French survey study

Anti-Donor HLA Antibody Response After Pancreatic Islet Grafting: Characteristics, Risk Factors, and Impact on Graft Function

Five-Year Metabolic, Functional, and Safety Results of Patients With Type 1 Diabetes Transplanted With Allogenic Islets Within the Swiss-French GRAGIL Network

Recent advances in renal transplantation: antibody-mediated rejection takes center stage